Charles Sharp

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Rituximab in autoimmune connective tissue disease–associated interstitial lung disease

Charles Sharp, Melanie McCabe, N Dodds et al. · Lara D. Veeken · 2016 · 91 citations · Full text

A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis

Charles Sharp, Huzaifa Adamali, Ann Millar · ERJ Open Research · 2017 · 45 citations · Full text

Defining the directionality and quality of influenza virus–specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus

Victoria Kasprowicz, Scott M. Ward, Alison Turner et al. · Journal of Clinical Investigation · 2008 · 43 citations · Full text

Mhc Class, Hepatitis C Virus, Immunology +16

South–West of England’s Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Shaney Barratt, Sarah Mulholland, Khaled Al Jbour et al. · Frontiers in Pharmacology · 2018 · 42 citations · Full text